GlassScriptPhysician profile
Shahriar Pirouz
NPI 1922201508
$42,682.69
in general payments reported to CMS, 2019-2025
31 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $319 · 2021: $384 · 2022: $1,436 · 2023: $6,495 · 2024: $19K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,039 · Food and Beverage: $7,612 · Travel and Lodging: $7,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,720.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,038.75 |
| Food and Beverage | $7,612.49 |
| Travel and Lodging | $7,583.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,951.38 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Accurian |
| Biotronik Nro, INC. | $12,480.75 | 2024-2025 | Prospera |
| Stryker Corporation | $1,059.11 | 2025 | Mild Device Kit |
| Medtronic USA, INC. | $563.56 | 2019-2020 | |
| Boston Scientific Corporation | $350.13 | 2020-2025 | Intracept |
| Abbvie INC. | $257.19 | 2021-2025 | |
| Si-Bone, INC. | $100.55 | 2022 | |
| Almatica Pharma LLC | $91.57 | 2021-2023 | Gralise |
| Pfizer INC. | $81.17 | 2019-2024 | |
| Vertex Pharmaceuticals Incorporated | $79.67 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $67.07 | 2021-2022 | |
| Painteq LLC | $59.82 | 2023 | Painteq |
| Nevro Corp. | $58.31 | 2019-2023 | Senza |
| Biodelivery Sciences International, INC. | $49.59 | 2019-2020 | |
| Heron Therapeutics, INC. | $48.00 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $42.63 | 2023 | Prialt |
| Grt US Holding, INC. | $41.66 | 2022 | |
| Allergan, INC. | $34.68 | 2021 | |
| Amgen INC. | $32.61 | 2019-2023 | Prolia, Evenity |
| Nalu Medical, INC. | $31.20 | 2024 | Nalu Neurostimulation System |
| Alnylam Pharmaceuticals INC. | $28.88 | 2021 | |
| Supernus Pharmaceuticals, INC. | $26.88 | 2020 | |
| Averitas Pharma INC. | $21.35 | 2023 | Qutenza |
| Relievant Medsystems, INC. | $19.11 | 2021 | |
| Bioventus LLC | $16.43 | 2025 | Xcell |
| Scilex Pharmaceuticals INC. | $16.27 | 2023 | Ztlido |
| Appliedvr INC | $16.06 | 2024 | Relievrx |
| Depuy Synthes Sales INC. | $15.51 | 2019 | |
| Assertio Therapeutics, INC. | $14.89 | 2019 | |
| Avanos Medical | $13.98 | 2024 | Genvisc 850 Sodium Hyaluronate |
| Forte Bio-Pharma LLC | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahriar Pirouz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.